EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma

Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer-Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M Melnick, Wendy Béguelin, Guy Ron und 1 weitere

PLOS Biology · 12.06.2025 · 23 (6) · e3003191

DOI: 10.1371/journal.pbio.3003191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 12.06.2025. Verfasst von Ofir Griess und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Gene Regulatory Networks, Lymphoma, B-Cell, Enhancer of Zeste Homolog 2 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Emerson Collective, The Israeli Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B cell lymphomas and follicular lymphomas show recurrent mutations in epigenetic regulators; among these are loss-of-function mutations in KMT2D and gain-of-function mutations in EZH2. To systematically explore the effects of these mutations on the wiring of the epigenetic network, we applied a single-cell approach to probe a wide array of histone modifications. We show that mutant-EZH2 elicits extensive effects on the epigenome of lymphomas, beyond alterations to H3K27 methylations, and is epistatic over KMT2D mutations. Utilizing the single-cell data, we present computational methods to measure epigenetic heterogeneity. We identify an unexpected characteristic of mutant-EZH2, but not KMT2D, in increasing heterogeneity, shedding light on a novel oncogenic mechanism mediated by this mutation. Finally, we present tools to reconstruct known interactions within the epigenetic network, as well as reveal potential novel cross talk between various modifications, supported by functional perturbations. Our work highlights novel roles for mutant-EZH2 in lymphomagenesis and establishes new concepts for measuring epigenetic heterogeneity and intra-chromatin connectivity in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticGene Regulatory NetworksLymphoma, B-CellEnhancer of Zeste Homolog 2 ProteinHumansMaleAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticMutationDNA-Binding ProteinsNeoplasm ProteinsSingle-Cell Gene Expression AnalysisHistonesProto-Oncogene Proteins c-bcl-6Germinal Center

Substanzen

EZH2 protein, humanEnhancer of Zeste Homolog 2 ProteinKMT2D protein, humanDNA-Binding ProteinsNeoplasm ProteinsHistonesBCL6 protein, humanProto-Oncogene Proteins c-bcl-6

Autor:innen und Institutionen

  • The Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Mass Cytometry Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Bioinformatics Unit, Department of Life Sciences Core Facilities, Faculty of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Division of Hematology, Weill Cornell Medical College, New York, New York, United States of America.
  • Department of Otolaryngology-Head and Neck Surgery, Hadassah Medical Center, Jerusalem, Israel.
  • Racah Institute of Physics, Hebrew University of Jerusalem, Jerusalem, Israel.

ORCID-Profile: Efrat Shema

Förderung

  • European Research Council
  • Emerson Collective
  • The Israeli Science Foundation
  • Israel Cancer Research Fund
  • Minerva foundation
  • Israeli Council for Higher Education (CHE)
  • Israeli science foundation
  • Ministry of Science, Technology and Space

Zitieren

APA

Griess, O., Furth, N., Harpaz, N., Di Bernardo, N., Salame, T. M., Dassa, B., Karagiannidis, I., Isshiki, Y., Gross, M., Melnick, A. M., Béguelin, W., Ron, G., & Shema, E. (2025). Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma. PLOS Biology, 23(6), e3003191. https://doi.org/10.1371/journal.pbio.3003191

Vancouver

Griess O, Furth N, Harpaz N, Di Bernardo N, Salame TM, Dassa B, et al. Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma. PLOS Biology. 2025;23(6):e3003191. doi:10.1371/journal.pbio.3003191

BibTeX
@article{Griess2025,
  author = {Griess, Ofir and Furth, Noa and Harpaz, Nofar and Di Bernardo, Nicoletta and Salame, Tomer-Meir and Dassa, Bareket and Karagiannidis, Ioannis and Isshiki, Yusuke and Gross, Menachem and Melnick, Ari M and Béguelin, Wendy and Ron, Guy and Shema, Efrat},
  title = {Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma},
  journal = {PLOS Biology},
  year = {2025},
  volume = {23},
  number = {6},
  pages = {e3003191},
  doi = {10.1371/journal.pbio.3003191}
}
Kostenlos starten →